UnitedHealth Group (UNH) abruptly canceled its Investor Day presentation shortly after it began this morning following media reports that the CEO of its insurance unit had been fatally shot.
Brian Thompson, who had led UNH's insurance segment since 2021, was shot in midtown Manhattan around 6:45 am Eastern Time on Wednesday morning, according to CNBC. He was transported to a local hospital in critical condition but was pronounced dead shortly thereafter.
UNH's Investor Day presentation had begun at 8:00 am Eastern Time in New York City, but quickly came to a close.
Sign up for Kiplinger’s Free E-Newsletters
Profit and prosper with the best of expert advice on investing, taxes, retirement, personal finance and more - straight to your e-mail.
Profit and prosper with the best of expert advice - straight to your e-mail.
"I'm afraid that we – some of you may know we're dealing with a very serious medical situation with one of our team members," UnitedHealth Group staff said during the presentation, according to the transcript obtained by CNBC. "And as a result, I'm afraid we’re going to have to bring to a close the event today, which I'm sure you'll understand."
Ahead of the presentation, UNH provided its outlook for fiscal 2025, calling for revenue in the range of $450 billion to $455 billion and earnings per share between $29.50 to $30.00.
"Overall, the outlook is in-line with expectations and represents a solid starting point for a company that guides conservatively, though the devil will be in the details," said Oppenheimer analyst Michael Wiederhorn, who has an Outperform (Buy) rating on the Dow Jones stock.
Where does Wall Street stand on UnitedHealth?
In fact, most of Wall Street is already bullish on the blue chip stock, even as its lagged the broad market this year. Indeed, shares of UNH are up 16% since the start of 2024 on a total return basis (price change plus dividends) basis vs the S&P 500's 28.5% gain.
According to S&P Global Market Intelligence, the average analyst target price for UNH stock is $629.19, representing implied upside of nearly 3% to current levels. Additionally, the consensus recommendation is Strong Buy.
Financial services firm UBS Global Research is one of the more bullish outfits on UNH stock with a Buy rating and $650 price target.
"Following the election, a Trump presidency is likely to be favorable to Medicare Advantage with higher rate updates and less regulation," says UBS analyst AJ Rice. "This puts UNH at the forefront to benefit the most as it gains market share in 2025 while remaining in its target margin range for MA. Additionally, a Republican administration is likely to be more lenient towards anti-trust, allowing UNH to have more acquisition opportunities long term."
Related Content
-
States That Won't Tax Your Retirement Income in 2025Retirement Taxes Several states don’t tax Social Security benefits, 401(k)s, IRAs, and pensions. But you may still have to pay state taxes on some incomes.
-
Build Your Dream Retirement With These Five StepsDreaming about life after work? Turn your dreams into a concrete, actionable plan by nailing down the why, what and how of your retirement.
-
Build Your Dream Retirement With These Five Steps
Dreaming about life after work? Turn your dreams into a concrete, actionable plan by nailing down the why, what and how of your retirement.
-
For Investors, 2024 Was a Year to RememberA perfect storm of favorable conditions created a rewarding landscape for investors. A buzz of cautious optimism continues for 2025.
-
Here's How Retirement Changes Your TaxesHow you approach taxes in your golden years and in the years before retirement can dramatically impact how much you pay.
-
Stock Market Today: Trump Tariff Worries Pressure StocksStocks swung lower Friday after the White House confirmed it will impose tariffs on Mexico, Canada and China beginning tomorrow.
-
Chevron Stock Declines Despite Another Dividend HikeChevron stock is down Friday after the integrated energy company missed fourth-quarter profit expectations. Here's what you need to know.
-
Why Walgreens Suspended Its DividendWalgreens stock is spiraling Friday after the pharmacy chain suspended its dividend amid continued turnaround plans. Here's what you need to know.
-
Intel Earnings Do Little to Excite Investors: What to KnowIntel stock is struggling for direction Friday after the chipmaker reported a fourth-quarter beat but gave weak guidance. Here's what Wall Street has to say.
-
Visa Stock Rises on Strong Earnings, Bullish OutlookVisa stock is up Friday after the payments company beat expectations for its fiscal 2025 first quarter and raised its outlook. Here's what you need to know.
